Trials / Conditions / Amyloid Cardiomyopathy

Amyloid Cardiomyopathy

22 registered clinical trials studyying Amyloid Cardiomyopathy — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy NCT07240844	Seoul St. Mary's Hospital	Phase 4
Not Yet Recruiting	To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM ( NCT07116473	Eidos Therapeutics, a BridgeBio company	Phase 3
Recruiting	Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes NCT07382128	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Recruiting	Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers NCT06563895	Eidos Therapeutics, a BridgeBio company	Phase 3
Not Yet Recruiting	AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA NCT06748261	Shanghai Zhongshan Hospital	—
Not Yet Recruiting	EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM) NCT06499064	Hospital Universitari de Bellvitge	N/A
Recruiting	Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy NCT06634108	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 1 / Phase 2
Recruiting	Exercise Training in Transthyretin Cardiac Amyloidosis NCT05797857	Brigham and Women's Hospital	N/A
Completed	Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amy NCT06261216	Medical University of Graz	—
Unknown	18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis NCT06048601	Fondazione Toscana Gabriele Monasterio	N/A
Unknown	Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation NCT05699044	Steen Hvitfeldt Poulsen	—
Unknown	Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amy NCT05452850	Istanbul University - Cerrahpasa	—
Unknown	Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemoth NCT05448716	Istanbul University - Cerrahpasa	—
Active Not Recruiting	Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy NCT05795400	National Medical Research Center for Cardiology, Ministry of Health of Russian Federation	N/A
Active Not Recruiting	Amyloidosis TTR Flow Reserve Evaluation NCT05103943	Centre Hospitalier Régional d'Orléans	N/A
Unknown	Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis NCT06328075	Algalarrondo Vincent	—
Unknown	Unmasking the Prevalence of AC in an Unselected Echocardiographic Population NCT04738266	University of Trieste	—
Completed	Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy NCT03860935	Eidos Therapeutics, a BridgeBio company	Phase 3
Unknown	Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study NCT03397810	Philippe Meyer	N/A
Active Not Recruiting	Open-Label Study of AG10 in Patients with Cardiomyopathy NCT03536767	Eidos Therapeutics, a BridgeBio company	Phase 2
Completed	Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis NCT03431896	The Cleveland Clinic	—
Recruiting	Swiss Cardiac Amyloidosis REgistry (Swiss-CARE) NCT04776824	Insel Gruppe AG, University Hospital Bern	—